483030·Stock-Sector-Healthcare
KIWOOM US Blockbuster Biotech Drugs Plus
Introduction
The KOSEF US Blockbuster Biotech Drugs Plus ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Solactive Blockbuster Biotech Drugs Index(PR)
Investment Points
ETF investing in companies that currently hold or are expected to hold blockbuster biotech drugs within the next 5 years.
Benchmark Index
Solactive Blockbuster Biotech Drugs Index
Benchmark Index Description
An index that invests in companies related to blockbuster pharmaceuticals listed in the United States. Blockbuster pharmaceuticals are given a title for products that generate over 1 billion dollars in annual revenue in the pharmaceutical and biotech industry; it is a major criterion for determining the commercial and practical success of biotech innovative technologies and the growth potential of a company.
Issuer
KIWOOM ASSET MANAGEMENT CO., LTD.
Brand
KIWOOM
Total Fee
0.49
Listing Date
2024-05-28
International Securities Code
KR7483030003
Market Information
Market Capitalization
9,768,000,000KRW
Transaction Amount
20,591,104KRW
Trading Volume
2,317
Shares Outstanding
1,100,000
NAV
9,006
52-Week High
10,740KRW
52-Week Low
8,880KRW